Aryeh Capital Management’s Comcast CMCSA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-207,806
Closed -$6.53M 4
2025
Q3
$6.53M Hold
207,806
5.46% 9
2025
Q2
$7.42M Hold
207,806
5.81% 11
2025
Q1
$7.67M Sell
207,806
-104,900
-34% -$3.78M 5.48% 10
2024
Q4
$11.7M Hold
312,706
7.03% 8
2024
Q3
$13.1M Hold
312,706
7.86% 7
2024
Q2
$12.2M Hold
312,706
7.86% 7
2024
Q1
$13.6M Hold
312,706
8.46% 7
2023
Q4
$13.7M Hold
312,706
8.29% 9
2023
Q3
$13.9M Hold
312,706
11.16% 7
2023
Q2
$13M Hold
312,706
9.58% 6
2023
Q1
$11.9M Sell
312,706
-438,200
-58% -$16.6M 9.17% 7
2022
Q4
$26.3M Sell
750,906
-473,700
-39% -$15.7M 19.53% 1
2022
Q3
$35.9M Buy
1,224,606
+809,389
+195% +$30.3M 17.2% 2
2022
Q2
$16.3M Sell
415,217
-500,000
-55% -$21.4M 6.56% 8
2022
Q1
$42.9M Buy
915,217
+88,500
+11% +$4.26M 14.28% 3
2021
Q4
$41.6M Buy
826,717
+417,056
+102% +$21.7M 14.37% 2
2021
Q3
$22.9M Buy
409,661
+111,600
+37% +$6.51M 8.92% 6
2021
Q2
$17M Hold
298,061
7.94% 6
2021
Q1
$16.1M Hold
298,061
8.45% 7
2020
Q4
$15.6M Buy
+298,061
New +$14.3M 8.5% 5

Other funds holding CMCSA

Aryeh Capital Management's CMCSA Position: Q4 2025 in Review

Aryeh Capital Management sold out of Comcast (CMCSA) in Q4 2025, closing a stake of 207,806 shares — an estimated $6.53M sold.

Aryeh Capital Management first reported a position in CMCSA in Q4 2020 and held it in 20 quarters. The position peaked at $42.9M in Q1 2022. 2,100 funds tracked by Wall St. Rank hold CMCSA as of Q4 2025.

  • Aryeh Capital Management reported no remaining Comcast position as of Q4 2025 after selling out during the quarter.
  • Aryeh Capital Management sold 207,806 Comcast shares in Q4 2025, an estimated $6.53M.
  • Aryeh Capital Management first reported a position in Comcast in Q4 2020 and held it in 20 quarters.
  • Aryeh Capital Management's Comcast position peaked at $42.9M in Q1 2022.
  • 2,100 funds tracked by Wall St. Rank held Comcast as of Q4 2025.

Based on Aryeh Capital Management's 13F filing for Q4 2025.